Expected earnings - Mustang Bio Inc.

Stock Information for Mustang Bio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Mustang Bio Inc.

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
Mustang Bio Announces Closing of $8 Million Public Offering
Mustang Bio Announces Pricing of $8 Million Public Offering
Mustang Bio Announces Reverse Stock Split
Mustang Bio Receives Positive Listing Determination from Nasdaq
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.